INO-4700 / GeneOne, Inovio  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INO-4700 / GeneOne, Inovio
NCT02670187: Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

Completed
1
75
US
GLS-5300
GeneOne Life Science, Inc., Inovio Pharmaceuticals, Walter Reed Army Institute of Research (WRAIR)
Healthy
05/17
09/17

Download Options